KiraGen Bio
Allston
About KiraGen Bio
KiraGen Bio is leveraging AI-driven, combinatorial gene editing to unlock the full potential of CAR-T cells against solid tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Nov 2023)
- Website: kiragenbio.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/kiragen-bio-2210979 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.